Table 1 Clinicopathological features of 22 patients

n

22

Median age^a (range)

57 (38–81)

Characteristics of primary tumour

 Histology

  IDC (NST)

18 (82%)

  Special type

4 (18%)

 Grade

  High

5 (23%)

  Low-intermediate

13 (59%)

  Unknown

4 (18%)

 Intrinsic subtype^b

  Luminal-HER2(−)

13 (59%)

  Luminal-HER2(+)

3 (14%)

  HER2

1 (5%)

  Triple negative

5 (23%)

  DFS (months)^c (range)

78 (12–125)

 Metastatic site

  Bone

13 (59%)

  Liver

8 (36%)

  Lungs

7 (32%)

  Pleura

2 (9%)

  Brain

2 (9%)

  Others

2 (9%)

 Number of previous chemotherapies for metastatic disease

  0

8 (36%)

  1–2

12 (55%)

  3−

2 (9%)